The Posters and Abstracts Presented By Prof. Dr. Rabab Gaafar

 

Prognostic factor analysis of EORTC 08983: A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM)

 

Treatment related quality of life findings in patients with malignant pleural mesothelioma: An international randomized Phase III study of cisplatin with or without raltitrexed

 

Prognostic value of performance status (PS) in advanced non-small cell lung cancer (NSCLC) patients receiving gemcitabine and cisplatin

 

Pemetrexed alone or in combination with cisplatin in the treatment of patients with advanced malignant mesothelioma: An open-label trial of the National Cancer Institute of Egypt

 

Malignant pleural mesothelioma role of surgery

 

A Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer

 
Diagnostic Pathology Review of EORTC 08983: A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM)

 

The Posters Presented By Prof. Dr. Rabab Gaafar